Clinical trial
A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters…
NCT00365924 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00365924 |
|---|---|
| Title | A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo |
| Official title | A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Recombinant Human Parathyroid Hormone, PTH (Forteo) |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Forteo |
| Enrollment | 20 |
| Start date | Dec 1, 2006 |
| Completion | Apr 1, 2008 |
| First posted | Aug 18, 2006 |
| Last update posted | Mar 23, 2009 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: